Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4H3X6
Term | Name | Level | Count |
---|---|---|---|
GO:0006470 | protein dephosphorylation | 5 | 9 |
GO:0006793 | phosphorus metabolic process | 3 | 9 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 9 |
GO:0006807 | nitrogen compound metabolic process | 2 | 9 |
GO:0008152 | metabolic process | 1 | 9 |
GO:0009987 | cellular process | 1 | 9 |
GO:0016311 | dephosphorylation | 5 | 9 |
GO:0019538 | protein metabolic process | 3 | 9 |
GO:0036211 | protein modification process | 4 | 9 |
GO:0043170 | macromolecule metabolic process | 3 | 9 |
GO:0043412 | macromolecule modification | 4 | 9 |
GO:0044237 | cellular metabolic process | 2 | 9 |
GO:0044238 | primary metabolic process | 2 | 9 |
GO:0071704 | organic substance metabolic process | 2 | 9 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 9 |
GO:0004721 | phosphoprotein phosphatase activity | 3 | 9 |
GO:0004725 | protein tyrosine phosphatase activity | 4 | 6 |
GO:0008138 | protein tyrosine/serine/threonine phosphatase activity | 4 | 9 |
GO:0016787 | hydrolase activity | 2 | 9 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 9 |
GO:0016791 | phosphatase activity | 5 | 9 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 9 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 9 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 138 | 140 | PF00082 | 0.295 |
CLV_PCSK_PC1ET2_1 | 138 | 140 | PF00082 | 0.295 |
CLV_PCSK_SKI1_1 | 203 | 207 | PF00082 | 0.462 |
CLV_PCSK_SKI1_1 | 44 | 48 | PF00082 | 0.315 |
DEG_COP1_1 | 7 | 15 | PF00400 | 0.376 |
DEG_MDM2_SWIB_1 | 166 | 173 | PF02201 | 0.438 |
DEG_SCF_FBW7_1 | 171 | 178 | PF00400 | 0.485 |
DOC_CKS1_1 | 172 | 177 | PF01111 | 0.324 |
DOC_CKS1_1 | 2 | 7 | PF01111 | 0.447 |
DOC_CYCLIN_yCln2_LP_2 | 162 | 168 | PF00134 | 0.426 |
DOC_MAPK_DCC_7 | 8 | 17 | PF00069 | 0.372 |
DOC_MAPK_gen_1 | 42 | 49 | PF00069 | 0.495 |
DOC_MAPK_MEF2A_6 | 8 | 17 | PF00069 | 0.372 |
DOC_PP2B_LxvP_1 | 162 | 165 | PF13499 | 0.435 |
DOC_PP2B_PxIxI_1 | 267 | 273 | PF00149 | 0.476 |
DOC_USP7_MATH_1 | 250 | 254 | PF00917 | 0.653 |
DOC_USP7_UBL2_3 | 203 | 207 | PF12436 | 0.604 |
DOC_WW_Pin1_4 | 1 | 6 | PF00397 | 0.460 |
DOC_WW_Pin1_4 | 160 | 165 | PF00397 | 0.378 |
DOC_WW_Pin1_4 | 171 | 176 | PF00397 | 0.370 |
DOC_WW_Pin1_4 | 194 | 199 | PF00397 | 0.412 |
DOC_WW_Pin1_4 | 230 | 235 | PF00397 | 0.599 |
LIG_14-3-3_CanoR_1 | 139 | 147 | PF00244 | 0.495 |
LIG_14-3-3_CanoR_1 | 176 | 180 | PF00244 | 0.438 |
LIG_Actin_WH2_2 | 31 | 46 | PF00022 | 0.430 |
LIG_APCC_ABBA_1 | 131 | 136 | PF00400 | 0.473 |
LIG_FHA_1 | 113 | 119 | PF00498 | 0.362 |
LIG_FHA_1 | 215 | 221 | PF00498 | 0.514 |
LIG_FHA_1 | 97 | 103 | PF00498 | 0.522 |
LIG_LIR_Apic_2 | 45 | 51 | PF02991 | 0.448 |
LIG_LIR_Gen_1 | 14 | 25 | PF02991 | 0.506 |
LIG_LIR_Gen_1 | 149 | 160 | PF02991 | 0.464 |
LIG_LIR_Gen_1 | 169 | 177 | PF02991 | 0.414 |
LIG_LIR_Gen_1 | 79 | 89 | PF02991 | 0.472 |
LIG_LIR_Nem_3 | 132 | 137 | PF02991 | 0.451 |
LIG_LIR_Nem_3 | 14 | 20 | PF02991 | 0.480 |
LIG_LIR_Nem_3 | 149 | 155 | PF02991 | 0.433 |
LIG_LIR_Nem_3 | 169 | 173 | PF02991 | 0.412 |
LIG_LIR_Nem_3 | 79 | 84 | PF02991 | 0.477 |
LIG_Pex14_2 | 166 | 170 | PF04695 | 0.426 |
LIG_SH2_CRK | 156 | 160 | PF00017 | 0.484 |
LIG_SH2_CRK | 196 | 200 | PF00017 | 0.498 |
LIG_SH2_PTP2 | 152 | 155 | PF00017 | 0.448 |
LIG_SH2_SRC | 54 | 57 | PF00017 | 0.482 |
LIG_SH2_STAT5 | 152 | 155 | PF00017 | 0.465 |
LIG_SH2_STAT5 | 204 | 207 | PF00017 | 0.467 |
LIG_SH2_STAT5 | 48 | 51 | PF00017 | 0.473 |
LIG_SH3_1 | 244 | 250 | PF00018 | 0.534 |
LIG_SH3_2 | 198 | 203 | PF14604 | 0.399 |
LIG_SH3_3 | 195 | 201 | PF00018 | 0.379 |
LIG_SH3_3 | 235 | 241 | PF00018 | 0.601 |
LIG_SH3_3 | 244 | 250 | PF00018 | 0.652 |
LIG_SH3_3 | 7 | 13 | PF00018 | 0.472 |
LIG_SUMO_SIM_par_1 | 129 | 136 | PF11976 | 0.516 |
LIG_TYR_ITIM | 194 | 199 | PF00017 | 0.500 |
MOD_CDK_SPK_2 | 171 | 176 | PF00069 | 0.466 |
MOD_CDK_SPxxK_3 | 1 | 8 | PF00069 | 0.451 |
MOD_CK1_1 | 129 | 135 | PF00069 | 0.448 |
MOD_CK1_1 | 227 | 233 | PF00069 | 0.679 |
MOD_CK1_1 | 36 | 42 | PF00069 | 0.393 |
MOD_CK2_1 | 129 | 135 | PF00069 | 0.495 |
MOD_CK2_1 | 179 | 185 | PF00069 | 0.433 |
MOD_GlcNHglycan | 209 | 212 | PF01048 | 0.598 |
MOD_GlcNHglycan | 226 | 229 | PF01048 | 0.645 |
MOD_GlcNHglycan | 252 | 255 | PF01048 | 0.686 |
MOD_GlcNHglycan | 257 | 260 | PF01048 | 0.644 |
MOD_GlcNHglycan | 26 | 29 | PF01048 | 0.264 |
MOD_GlcNHglycan | 38 | 41 | PF01048 | 0.264 |
MOD_GlcNHglycan | 93 | 96 | PF01048 | 0.242 |
MOD_GSK3_1 | 11 | 18 | PF00069 | 0.589 |
MOD_GSK3_1 | 171 | 178 | PF00069 | 0.393 |
MOD_GSK3_1 | 224 | 231 | PF00069 | 0.731 |
MOD_GSK3_1 | 24 | 31 | PF00069 | 0.477 |
MOD_GSK3_1 | 262 | 269 | PF00069 | 0.674 |
MOD_N-GLC_1 | 15 | 20 | PF02516 | 0.368 |
MOD_N-GLC_1 | 207 | 212 | PF02516 | 0.650 |
MOD_N-GLC_1 | 33 | 38 | PF02516 | 0.279 |
MOD_NEK2_1 | 166 | 171 | PF00069 | 0.415 |
MOD_NEK2_1 | 229 | 234 | PF00069 | 0.662 |
MOD_PIKK_1 | 245 | 251 | PF00454 | 0.674 |
MOD_PK_1 | 42 | 48 | PF00069 | 0.516 |
MOD_PKA_2 | 175 | 181 | PF00069 | 0.470 |
MOD_Plk_1 | 15 | 21 | PF00069 | 0.487 |
MOD_Plk_1 | 33 | 39 | PF00069 | 0.479 |
MOD_Plk_4 | 114 | 120 | PF00069 | 0.590 |
MOD_Plk_4 | 129 | 135 | PF00069 | 0.368 |
MOD_Plk_4 | 166 | 172 | PF00069 | 0.438 |
MOD_Plk_4 | 175 | 181 | PF00069 | 0.390 |
MOD_Plk_4 | 262 | 268 | PF00069 | 0.601 |
MOD_ProDKin_1 | 1 | 7 | PF00069 | 0.455 |
MOD_ProDKin_1 | 160 | 166 | PF00069 | 0.379 |
MOD_ProDKin_1 | 171 | 177 | PF00069 | 0.362 |
MOD_ProDKin_1 | 194 | 200 | PF00069 | 0.414 |
MOD_ProDKin_1 | 230 | 236 | PF00069 | 0.599 |
MOD_SUMO_rev_2 | 132 | 140 | PF00179 | 0.495 |
TRG_DiLeu_BaLyEn_6 | 100 | 105 | PF01217 | 0.495 |
TRG_ENDOCYTIC_2 | 137 | 140 | PF00928 | 0.483 |
TRG_ENDOCYTIC_2 | 152 | 155 | PF00928 | 0.483 |
TRG_ENDOCYTIC_2 | 156 | 159 | PF00928 | 0.522 |
TRG_ENDOCYTIC_2 | 196 | 199 | PF00928 | 0.493 |
TRG_ER_diArg_1 | 41 | 44 | PF00400 | 0.516 |
TRG_Pf-PMV_PEXEL_1 | 184 | 188 | PF00026 | 0.469 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JUF6 | Bodo saltans | 64% | 93% |
A0A3S5H5B2 | Leishmania donovani | 77% | 93% |
A0A422N9L9 | Trypanosoma rangeli | 76% | 90% |
A4HS51 | Leishmania infantum | 77% | 93% |
C9ZY49 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 72% | 89% |
E9AK38 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 81% | 98% |
Q95Z86 | Leishmania major | 79% | 100% |